November 2020 Volume 16, Issue 10

Volume 16, Issue 10 | November 2020

November 2020

In this Issue

Business & Government Policy

Drug Discovery News Placeholder Image

Returning to the fold

Illumina acquires cancer-focused GRAIL for $8 billion
Drug Discovery News Placeholder Image

On the cutting edge

A roundup of instrumentation, software and other tools and technology news
Drug Discovery News Placeholder Image

No more EUAs for COVID-19 tests

FDA makes a change in its policy of reviewing and granting tests related to the pandemic
Drug Discovery News Placeholder Image

A seed fund to drive biopharma innovation

Pistoia Alliance looks to finance four projects annually from idea to proof of concept

Contract Services

Drug Discovery News Placeholder Image

Europital expands into a full-service CRO

New capabilities include project management, clinical monitoring and pharmacovigilance
Drug Discovery News Placeholder Image

An acquisition opportunity for CMOs?

Indian dose sites an untapped M&A opportunity for foreign contract manufacturers

Diagnostics

Drug Discovery News Placeholder Image

A promising biomarker for diagnosing liver disease

Owlstone study pinpoints limonene for early diagnosis of NASH and NAFLD
Drug Discovery News Placeholder Image

Keeping an eye on neurodegeneration

Potential biomarker for Alzheimer’s, Parkinson’s and other diseases can be found in the eye
Drug Discovery News Placeholder Image

Bionano Genomics acquires Lineagen

Deal boosts capacity in digital cytogenetics and adds genetic diagnostics for neurodevelopmental disorders

Clinical Trials

Drug Discovery News Placeholder Image

Special delivery

Natural compound attacks Alzheimer’s disease early
Drug Discovery News Placeholder Image

Medable offers fully remote options

Informed consent and re-consent made possible for trials without being physically present
Drug Discovery News Placeholder Image

Commentary: Adapting to a decentralized model during COVID-19 and beyond

Even after the coronavirus is tamed, changes being made now to clinical trial design and execution could benefit the clinical research industry moving forward
Drug Discovery News Placeholder Image

Targeting beta amyloid oligomers

Four compounds show promise against Alzheimer’s

Preclinical

Drug Discovery News Placeholder Image

New means for managing myotonic dystrophy

RNA-targeting gene therapy reverses molecular and functional features of DM1 in mice
Drug Discovery News Placeholder Image

Preclinical pancreatic cancer partnership

Relationship targets use of pipeline drug and AI platform
Drug Discovery News Placeholder Image

BioNTech and Pfizer report BNT162b2 data

BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2
Drug Discovery News Placeholder Image

Hope for frontotemporal dementia patients

Passage Bio plans Phase 1/2 trial of gene therapy in humans based on preclinical results

Research & Development

Drug Discovery News Placeholder Image

Building a database around RNA and proteins

eCLIP technology helps uncover how RNA binding proteins regulate gene expression
Drug Discovery News Placeholder Image

An antisense-ible arrangement

Evotec and Secarna partner on antisense-based therapeutics
Drug Discovery News Placeholder Image

Pressure to deliver

Researchers pave a way toward painless transdermal drug delivery
Drug Discovery News Placeholder Image

Developing a cell therapy control switch

Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies

Discovery

Drug Discovery News Placeholder Image

Game-changer

Druggable pocket in SARS-CoV-2 spike protein could stop virus
Drug Discovery News Placeholder Image

Finding new drugs with fungi

NIH grant will help researchers learn ways to counter drug resistance via gene editing
Drug Discovery News Placeholder Image

Getting the lowdown on GLO2

Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolism
Drug Discovery News Placeholder Image

Arctoris and Syntekabio form research partnership

First step is to assess potential therapeutics for COVID-19
Drug Discovery News Placeholder Image

A better targeting system

Genetic study of protein levels in diseases could help pinpoint optimal therapeutic targets

Feature

Drug Discovery News Placeholder Image

Focus Feature on  Cancer Research News: Cellular insights into cancer

Understanding behavior, responses and evolution of cells aids in oncology efforts
Drug Discovery News Placeholder Image

Spotlight on Cell Biology: Cell biology takes the stage

ASCB|EMBO annual meeting goes virtual this year with cellular research. Two of the most significant changes aside from the online format are that the meeting will feature seven scientific tracks plus an education and professional development track, in addition to member-organized Special Interest Subgroups being held on three days of the meeting. 

Editor's Focus

Drug Discovery News Placeholder Image

Keeping tabs on infectious disease

A look at our new online venue for infectious diseases as well as upcoming coverage
Drug Discovery News Placeholder Image

Science on fast-forward

Many don’t realize how little “settled science” we’ve got, and the last nine months have brought science out front on a new scale
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue